The Hershey Company Announces Offering of Notes
HERSHEY, Pa., May 27, 2020 (GLOBE NEWSWIRE) — The Hershey Company (NYSE: HSY) announced today that it is offering to […]
Century Metals Announces Update on Acquisition of Reyna Silver Corp.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES.TORONTO, May 27, 2020 (GLOBE NEWSWIRE) — […]
Tarku announces results from its Annual General and Special Meeting and a Corporate update
MONTREAL, May 27, 2020 (GLOBE NEWSWIRE) — Tarku Resources Ltd (TSX-V: TKU) (the “Company” or “Tarku”) is pleased to announce […]
Corbus Pharmaceuticals Reports Last Subject Visit in RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
Topline data on schedule for summer 2020Systemic sclerosis (SSc) is a rare, serious and life-threatening autoimmune disease affecting ~200,000 people […]
Menlo Therapeutics Announces Covered Status for AMZEEQ® (minocycline) topical foam, 4%, on Additional Commercial Formulary
Coverage Effective Immediately on One of the Largest Payor Networks in the U.S.AMZEEQ® is the First FDA Approved Topical Form […]
Vir Biotechnology Initiates Phase 1 Clinical Trial of VIR-3434 for Chronic Hepatitis B Virus Infection
SAN FRANCISCO, May 27, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the initiation of a Phase […]
Corvus Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference
BURLINGAME, Calif., May 27, 2020 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development […]
Bionano to Participate in Maxim Group’s Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on Testing
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that Erik Holmlin, Ph.D., CEO […]
Neoleukin Therapeutics to Present at Jefferies Virtual Healthcare Conference
SEATTLE, May 27, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to […]
Morphic to Present at the Jefferies Virtual Healthcare Conference
WALTHAM, Mass., May 27, 2020 (GLOBE NEWSWIRE) — Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of […]
